Hosted on MSN1mon
Penumbra spikes after Stryker- Inari deal
Penumbra (PEN) is “likely to carry the most ... thrombectomy technology for peripheral vascular diseases like DVT and PE,” Jennings, with a Buy recommendation on Stryker (SYK), added.
Nasdaq10d
Should You Add Penumbra Stock to Your Portfolio Right Now?
Penumbra, Inc.’s PEN thrombectomy business is thriving, driven by growing sales of the U.S. vascular thrombectomy and CAVT (computer-assisted vacuum thrombectomy) line of products. The company ...
WTOP News4d
Penumbra: Q4 Earnings Snapshot
ALAMEDA, Calif. (AP) — ALAMEDA, Calif. (AP) — Penumbra Inc. (PEN) on Tuesday reported fourth-quarter profit of $33.7 million. On a per-share basis, the Alameda, California-based company said ...
Seeking Alpha3d
Penumbra targets 13%-14% revenue growth for 2025 with focus on thrombectomy market expansion
Penumbra closed 2024 on a strong note, driven by robust growth in its U.S. thrombectomy business and the successful introduction of new CAVT products. Despite challenges in the China market and ...